Phase III Study of Sorafenib in Patients With Renal Cell Carcinoma (RCC)

Clinical trial NCT00586105 · COMPLETED

Trial details

NCT number: NCT00586105
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Renal Cell

Start date: 2005-12-01
Primary completion: 2008-05-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.